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Abstract.  We have investigated mechanisms involved 
in integrin-mediated signal transduction in platelets by 
examining integrin-dependent phosphorylation and ac- 
tivation of a newly identified protein tyrosine kinase, 
pp125 F~ (FAK,  focal adhesion kinase). This kinase 
was previously shown to be localized in focal adhe- 
sions in fibroblasts, and to be phosphorylated on tyro- 
sine in normal and Src-transformed fibroblasts. We 
show that thrombin and collagen activation of platelets 
causes an induction of tyrosine phosphorylation of 
pp125 F~ and that pp125 F~ molecules isolated from ac- 
tivated platelets display enhanced levels of phosphor- 
ylation in immune-complex kinase assays,  pp125 F~ 
was not phosphorylated on tyrosine after thrombin or 
collagen treatment of Glanzmann's thrombasthenic 
platelets deficient in the fibrinogen receptor GPIIb- 
IIIa, or of platelets pretreated with an inhibitory 
monoclonal antibody to GP lib-Ilia.  Fibrinogen bind- 
ing to GP Ub-HIa was not sufficient to induce 
pp125 F~x phosphorylation because pp125 F~ was not 
phosphorylated on tyrosine in thrombin-treated plate- 
lets that were not allowed to aggregate. These results 
indicate that tyrosine phosphorylation of pp125 s~  is 
dependent on platelet aggregation mediated by fibrino- 
gen binding to the integrin receptor GP lib-Ilia.  The 
induction of tyrosine phosphorylation of pp125 F~ was 
inhibited in thrombin- and collagen-treated platelets 
preincubated with cytochalasin D, which prevents actin 
polymerization following activation. Under all of these 
conditions, there was a strong correlation between the 
induction of tyrosine phosphorylation of pp125 r~ in 
vivo and stimulation of the phosphorylation of 
pp125 FA~ in vitro in immune-complex kinase assays. 
This study provides the first genetic evidence that 
tyrosine phosphorylation of pp125 F~ is dependent on 
integrin-mediated events, and demonstrates that there 
is a strong correlation between tyrosine phosphoryla- 
tion of pp125 FAK in platelets, and the activation of 
pp125FAK-associated phosphorylating activity in vitro. 
T 
HE  interactions  of cells with extracellular adhesion 
molecules play critical roles  in regulating  the mor- 
phology, proliferation,  migration, and differentiation 
of cells. One family of receptors for extracellular adhesion 
molecules,  called integrins,  is comprised of heterodimeric 
r  transmembrane proteins (1, 17, 19, 20). Although the ex- 
tracellular interactions between  adhesion molecules  and their 
integrin receptors have been well characterized, the interac- 
tions of integrins with cytoplasmic targets and their role in 
signaling pathways that are responsible for adhesion-induced 
changes in cell behavior are poorly understood (5). 
Platelets provide a very useful model system for investigat- 
ing the mechanisms involved in integrin-induced  events. The 
best characterized platelet integrin receptor, GP Hb-HIa, is 
required for two essential  functions of platelets  in hemo- 
stasis-platelet-to-platelet aggregation and the spreading of 
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platelets on blood vessel subendothehum (23, 25, 26, 33, 34). 
The interactions of GP Ilb-IBa with adhesion molecules are 
also important for activation of intracellular pathways that 
regulate several processes,  including  the activation  of the 
Na+/H  § antiporter and the Ca2+-dependent  protease, calpain 
(2, 12). In platelets treated with weak agonists, such as ADP, 
aggregation mediated by fibrinogen binding to GP llb-lIIa is 
also required for the stimulation of arachidonate metabolism 
and dense granule secretion (2,  18, 29, 30). 
The mechanisms involved in signaling through GP llb-ITla 
remain elusive.  Recent studies have shown that thrombin- 
induced tyrosine phosphorylation of several proteins is de- 
pendent on platelet aggregation mediated  by fibrinogen bind- 
ing  to  GP Hb-lIIa  (11, 14). These results  suggested  that 
tyrosine phosphorylation might be involved in GP llb-BIa- 
regulated cellular processes. Furthermore, in NIH-3T3 cells 
and human epidermal carcinoma KB cells,  engagement of 
integrins by receptor cross-linking  or spreading on a fibro- 
nectin matrix induced tyrosine phosphorylation of several 
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cate tyrosine  phosphorylation of  cellular proteins in intracel- 
lular events triggered by integrin receptors. 
A candidate protein tyrosine kinase that may be involved 
in integrin-regulated tyrosine phosphorylation has been iden- 
tified. This protein, denoted pp125  FAK (FAK, focal adhesion 
kinase),  was  first identified  using  monoclonal antibodies 
(mAbs) raised against phosphotyrosine-containing  proteins 
isolated  from pp60  ....  transformed cells (22).  In normal 
fibroblasts,  pp125  FAK is  localized  in  focal  adhesions,  and 
displays a  low level of tyrosine phosphorylation (22,  28; 
B. S. Cobb and J. T. Parsons, unpublished results). Tyrosine 
phosphorylation of this protein is enhanced  three- to fivefold 
in  Rous  sarcoma virus infected  cells  expressing  pp60  ~-'~ 
(22).  The  cDNA  encoding pp125  FAK contains  sequences 
that are highly homologous to those found in the catalytic 
domains of protein tyrosine kinases, and expression of this 
eDNA in Escherichia coli causes an induction of tyrosine 
phosphorylation of many bacterial  proteins.  In addition,  a 
TrpE-fusion protein containing the sequences corresponding 
to  the catalytic domain of this  eDNA  was  able  to  au- 
tophosphorylate in  immune-complex kinase assays  (28). 
This protein tyrosine kinase has been implicated in integrin- 
signaling pathways by the evidence that it represents at least 
one of the 115- to 130-kD proteins that are phosphorylated 
on tyrosine following  cross-linking  of integrin receptors 
on KB cells  (L.  J.  Kornberg  and R.  L. Juliano,  personal 
communication) or following plating  of NIH-3T3  cells or 
chicken embryo fibroblasts (CEFs) ~  on fibronectin matrices 
(J. L. Guan, I. Chackalaparampil,  and D. Shalloway, per- 
sonal communication; M. D. Schaller, B. S. Cobb, and J. T. 
Parsons,  unpublished  results). 
We have examined integrin-mediated regulation of tyro- 
sine phosphorylation and activity of pp125  rA~ in platelets. 
Both thrombin and collagen-stimulated platetet activation led 
to an induction of tyrosine phosphorylation of pp125  FAK. In 
addition,  we show that p125  FAK phosphorylating  activity in 
vitro strongly correlates with tyrosine phosphorylation of 
pp125 FAK in vivo. Furthermore, we have taken advantage of 
the availability of  platelets that are genetically  deficient in GP 
IIb-IIIa to show that thrombin- or collagen-induced  tyrosine 
phosphorylation of pp125  ~AK, and stimulation  of its phos- 
phorylating activity in vitro,  are dependent on fibrinogen 
binding to GP IIb-IIIa. These results provide the first genetic 
evidence linking integrin receptors with tyrosine  phosphory- 
lation of pp125  ~AK, and the first demonstration that tyrosine 
phos~horylation of pp125  FAK in vivo correlates with activa- 
tion of the phosphorylating  activity of this protein tyrosine 
kinase in vitro. 
Materials and Methods 
Platelet Preparation and Activation 
Human ptatetets were isolated by gel filtration from freshly drawn blood an- 
ticoagulated with 0.15 vol NIH formula A acid-citrate-dextrose solution 
supplemented  with  t  tzM prostaglandin  E1 (PGEO O1).  Briefly, platelet- 
rich plasma was prepared by sedimentation of blood at 180 g for 20 rain. 
The platetets were concentrated by an additional sedimentation at 900 g fur 
I5 rain,  resuspended in 3 mt plasma supplemented with 1 ttM PGE~ and 
1. Abbreviations used in this paper. CEF, chicken embr~ fibroblast; CD, 
cytochalasin  D; FAK, focal adhesion kinase;  PGEI, prostaglandin  El. 
1 U/ml apyrase, and filtered over a Sepharose-2B column equilibrated  in 
137 mM NaC1, 2.7 mM KCl,  1 mM MgCl2, 5.6 mM glucose,  1 mg/ml 
BSA, 3.3 mM NaH2PO4, and 20 mM Hepes, pH 7.4.0.5 nil of gel-filtered 
platelets at a concentration of 3-6 x  l0  s platelets/ml were left untreated or 
incubated for the indicated time in the absence or presence of ct-thrombin 
(1 U/rnl; Chrono-Log Corp., Havertown,  PA), collagen (5 ~g/ml; Sigma 
Chemical Co., St. Louis, MO), or ADP (10 #M, Chrono-Log Corp.), epi- 
nephrine (10 ~M, Chrono-Log Corp.),  and fibrinogen (50 #g/ml, Chrono- 
Log Corp.).  Unless otherwise indicated, the platalets were stirred at 1,000 
rpm during the incubation. At the end of the activation period the platelets 
were lysed by the addition of an equal volume of 2 ￿  modified RIPA buffer 
(lx  is  1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS,  158 mM 
NaC1, l0 mM Tris-HC1, pH 7.2,  1 mM sodium EGTA,  I  mM phenyl- 
methylsnifonylfluoride  [PMSF],  1 mM Na3VO4 [Fisher  Scientific Co., 
Pittsburgh,  PAL and  100 kallikrein  inactivator units/ml of Trasylol [FBA 
Pharmaceuticals,  West Haven, CT]) at 4~  for 30 min.  In some experi- 
ments, platelets were pretreated with 10 #M cytochalasin D (Aldrich Chem- 
ical Co., Milwaukee, Wl) for 20 min before their stimulation with thrombin 
or collagen.  In other experiments,  the get-filtered platelets  were prein- 
cubated for 20 rain with the anti-GP I~-llla mAb 7E3 (10 t,g/ml) or mAb 
10E5 (20 t~g/ml) generously provided by Robert Jordon (Centocor,  Inc, 
Malvern,  PA) and Barry Culler (State University of New York of Stony 
Brook), respectively. Collagen binding to GP Ia-IIa was prevented by prein- 
cubating the gel-filtered platelets for 20 rain with the anti-GP Ia-IIa mAb 
6FI (20 ~,g/ml) (8), generously provided by Barry Culler (State University 
of New York at Stony Brook). 
Identification of  Phosphotyrosine-Containing Proteins 
by Immunoblotting 
Platelet  lysates or immunoprecipitates  (from 8 to 10  x  l0  s cells) were 
subjected to SDS-PAGE on 7.5 % gels. Proteins were transferred to nitroceb 
lulose and the blot was incubated for 16 h in blocking solution (5 % Cohn 
crystallized  BSA lieN Biomedicals,  Inc.,  Costa  Mesa,  CAI,  170 mM 
NaCl, 0,2% NP-40, 50 mM Tris, pH 7.5). Immunoblots were probed with 
a mixture of two anti-phosphotyrosine mAbs in buffer A 0 % BSA, 170 mM 
NaCl, 0.2% NP-40, 50 mM Tris-HC1 [pH 7.5]). The antibodies were mAb 
4G10 (1 tzg/ml) (10), kindly provided by Tom Roberts (Dana Farher Cancer 
Research Institute, Boston, MA), and mAb PY20 (1 ~g/ml) (ICN Biomedi- 
otis, Inc., Costa Mesa, CA). Nitrocellulose filters were washed four times 
in buffer B (buffer A without BSA), incubated with buffer A for 30 rain, 
and  then  for  2  h  with  a  t:1,500  dilution  of horseradish  peroxidase- 
conjugated goat-anti-mouse IgG (Bio-Rad Laboratories, Richmond, CA) in 
buffer A. Immunoreactivity was determined using the ECL chemilumines- 
cence reaction (Amersham Corp., Arlington Heights, ILL 
Immunoprecipitation and Kinase Assays 
RIPA extracts were clarified at 25,000 g for 30 rain. This and all subsequent 
steps were carried out at 4~  For immunoprecipitation of  phosphotyrosine- 
containing proteins, lysates were incubated with polyclonal rabbit anti-phos- 
photyrosine antibodies (from rabbit UP28), that had been affinity-purified 
on a phosphotyrosine column (32). Control  samples were incubated with 
1/zgtml of rabbit anti-mouse immunoglobulin (RAM), For immunopreci- 
pitation of pp125  FAK, RIPA Iysates were precleared  twice with Pansorbin 
by sedimentation at t6D00 g for 15 rain and then incubated with mAb 2A7 
(10 t~g/ml) plus RAM, or a polyctonat antiserum  to pp125  tar (28).  Im- 
mune complexes were incubated for 30 min with 30 ~tl/ml of Pansorbin or 
PansorbLa precoated  with  1 ~g/ml of RAM.  Immunoprecipitates  were 
washed three times in RIPA buffer. To examine tyrosine phosphorylation of 
platelet proteins or pp125  FAK) immunoprecipitates  were eluted from Pan- 
sorbin,  separated by SDS-PAGE, and irmnunoblotted onto nitrocellulose 
filters which where then probed with anti~phosphotyrosine mAhs, 4G10 or 
PY20 as described above. To examine the autophospborylating  activity of 
pp125 FAK, immunoprecipitates  were washed twice in RIPA buffer, once 
with low salt buffer (100 mM NaC1, 10 mM Tris, pH 7.5, 5 mM MnC12) 
and incubated in 30 ~  of kinase reaction mixture containing  I0 mM Tris, 
pH 7.4, 5 mM MnCI2, 1/~M ATE and 10 #Ci[732P]ATP [1 Ci=37 GBq, 
ICN] for 5 min at room temperature.  The kinase reaction was stopped by 
the addition of t ml of RtPA buffer at 4~  The phosphorylated  proteins 
were eluted from the Pansorbin, and separated by etectrophoresis on SDS/ 
7.5 % potyacrylamide gels as described.  Phosphorylated proteins were de  ~ 
tected  by autoradiography.  Gets containing  32pqaheled proteins  were rv 
hydrated in destaining solution (10% methanol, 5 % acetic acid), and then 
treated with I M KOH for 2 h at 56~  to remove alkali-labile phosphate (9). 
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tyrosine  phosphorylation  in throm- 
bin-stimulated platelets. Gel-ill- 
tered platelets from a normal do- 
nor (lanes 1-7) or from a donor 
with  Glanzmann's thrombasthe- 
nia (lanes 8-14) were stirred in 
the absence of agonist (lanes 1, 3, 
8,  and  10), or  with  thrombin 
(THR; 1 U/ml) for 30 s (lanes 4 
and 11), 1 min (lanes 5 and 12), 
2 min (lanes 6 and 13), or 5 min 
(lanes 7 and 14), and then lysed 
in R/PA buffer. Lysates were in- 
cubated with anti-pp125  mK mAb 
2A7 plus RAM (pp125F^g; lanes 
3-7 and  4-10),  or  with  RAM 
alone (RAM; lanes 1, 2, 8, and 
9). Immunoprecipitated proteins 
were analyzed on  immunoblots 
and probed with mAbs specific 
for phosphotyrosine residues. 
Results 
I~yrosine Phosphorylation of  ppl25  ~AK in 
Thrombin-Treated Platelets 
Thrombin treatment of platelets isolated from peripheral 
blood initiates a cascade of changes in cell physiology that 
mimic many of the events associated with platelet activation 
in vivo, including activation of intracellular signaling path- 
ways leading to the secretion of alpha and dense granules 
(23). Fibrinogen molecules released from alpha granules bind 
to GP IIb-INa, and subsequent interactions of  platelet-bound 
fibrinogen molecules lead to platelet aggregation (23). 
To determine if pp125 F^K is phosphorylated on tyrosine in 
activated platelets, pp125 F^~ was immunoprecipitated from 
lysates of  resting or thrombin-treated platelets, transferred to 
nitrocellulose,  and probed  with mAbs  specific for phos- 
photyrosine residues  (Fig.  1).  The  pp125 F^K immunopre- 
cipitates from untreated platelets did not show any reactivity 
with the mAbs  to phosphotyrosine.  However,  a  125,000 
Mr phosphotyrosine-containing protein was immunoprecip- 
itated from all thrombin-treated platelet lysates 0anes 5-7). 
This protein displayed the predicted electrophoretic mobility 
of pp125 F^K, and was not detected in control antibody im- 
munocomplexes from thrombin-treated platelets  (lane  2). 
Preincubation of these blots with 200/~M phosphotyrosine 
completely  blocked  immunoreactivity  with  the  mAb  to 
phosphotyrosine.  The  antiphosphotyrosine  immunoreac- 
tivity of pp125 F~ reached its highest level within 1 rain af- 
ter thrombin treatment,  and was maintained at this level 
throughout the  time period  examined  (5  min)  (data  not 
shown).  Under  our  conditions  of platelet  isolation  and 
thrombin treatment, dense granule secretion occurs within 
seconds of  thrombin stimulation, and aggregation follows af- 
ter 30-60 s. Thus, the time course of pp125 F^K phosphory- 
lation suggested that tyrosine phosphorylation of pp125 FAK 
might occur after platelet aggregation. 
Fibrinogen binding to GP llb-llIa and subsequent platelet 
aggregation are necessary for tyrosine phosphorylation of 
several proteins in thrombin-treated platelets (11, 14). We ex- 
amined whether tyrosine phosphorylation of pp125 F^X was 
dependent on fibrinogen binding to GP l/b-IIIa by analyzing 
tyrosine phosphorylation of pp125 F^z in  thrombin-treated 
platelets  from  GP  lib-Ilia-deficient donors  with  Glanz- 
mann's thrombasthenia (Fig.  1,  lanes  8-14).  Glanzmann's 
platelets undergo normal secretion of alpha and dense gran- 
ules after thrombin stimulation, but are unable to aggregate 
(34). There was no detectable phosphorylation of pp125 FAK 
in Glanzmarm's platelets (lanes 10-14), however, we detected 
normal levels of pp125 F^K in these platelets in immunoblot 
assays (data not shown). These results indicate that tyrosine 
phosphorylation  of pp125 r^~  is  dependent  on  fibrinogen 
binding to GP IIb-IIIa. 
pp125  rA~ Phosphorylation in Collagen-Treated Platelets 
Tyrosine phosphorylation of pp125 F^~: was also examined in 
platelets treated with collagen, which interacts with another 
integrin  receptor,  GP  Ia-lla  (c~)  (Fig.  2)  (27).  Like 
thrombin, collagen causes full activation ofplatelet secretion 
and aggregation (3).  Collagen binding to  platelets  is  in- 
hibited by antibodies to GP Ia-IIa (8), yet collagen-induced 
platelet aggregation is dependent on fibrinogen interaction 
with GP IIb-IIIa. In normal platelets, collagen induced tyro- 
sine phosphorylation of pp125 FAK at levels similar to those 
induced by thrombin (lanes 2 and 3). As in thrombin-treated 
platelets,  the  induction  of  tyrosine  phosphorylation  of 
pp125 r^K by collagen was dependent on GP IIb-IIIa because 
pp125 F^K was  not detectably phosphorylated in collagen- 
treated Glanzmann's platelets (lane 8). Thus, agonist engage- 
ment of the integrin collagen receptor is not sufficient to in- 
duce  tyrosine  phosphorylation  of  pp125 FAK  in  platelets 
deficient in GP l/b-IIIa, suggesting that fibrinogen binding 
to GP IIb-Kla and/or platelet aggregation might be required 
for the induction of pp125 FAK phosphorylation. 
Stimulation of  ppl25  rAx Protein Tyrosine Kinase Activity 
pp125 F^K was  recently shown to  be  capable of autophos- 
phorylation when expressed  as  a  TrpE  fusion protein  in 
E.  coli (28).  To examine whether the catalytic activity of 
pp125 F^K is stimulated by thrombin, pp125 FAK immunopre- 
cipitates from untreated or thrombin-treated platelets were 
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thrombin- or collagen-treated platelets. Gel-filtered platelets from 
a normal donor  (lanes 1-5) or from a donor with Glanzmann's 
thrombasthenia (lanes 6--10) were stirred for 2 min in the absence 
of agonist (UN; lanes 1 and 6), with thrombin (THR; lanes 2, 5, 
7, and 10), or with collagen (COL; lanes 3-4 and 8-9), and lysed 
in RIPA buffer. Lysates  were incubated with anti-pp125  FAK mAb 
2A7 plus  RAM (pp125FAK; lanes 1-3 and  6--8), or with RAM 
alone (RAM; lanes 4, 5, 9, and 10). Immunoprecipitated proteins 
were analyzed on immunoblots and probed with mAbs specific for 
phosphotyrosine residues. 
incubated with [-?32P]ATP (Fig.  3 A).  Under these condi- 
tions, only a low level of phosphate was incorporated into 
a 125-kD protein in anti-pp125 FAK immunoprecipitates from 
untreated platelets (lane/).  However,  platelet activation by 
thrombin resulted in enhanced 32p-incorporation  into this 
protein (lanes 2 and 3). Control immunoprecipitates did not 
contain a similar phosphorylated protein (lane 4).  Several 
other 32p-labeled proteins of Mr 56,000,  62,000, and 73,000 
were  detected  in  these  assays.  Since  the  proteins  of Mr 
73,000  and 62,000  were also observed in the control im- 
munoprecipitates (lane 4), they appear to represent nonspe- 
cific phosphorylated proteins. The 56-kD protein detected in 
anti-pp125 F^K  immunoprecipitates  from  thrombin-treated 
platelets  could  represent  a  coprecipitating  substrate  of 
pp125 F^K, a coprecipitating protein kinase, or a protein that 
nonspecifically associated with the immune complexes. The 
phosphate label on the Mr 125,000 and 56,000  proteins was 
stable to alkali treatment strongly suggesting that these pro- 
teins may be phosphorylated on tyrosine (Fig. 3 B). Phos- 
phoamino acid analysis of pp125  FAK labeled in vitro revealed 
phosphotyrosine only (M. D. Schaller and J. T. Parsons, data 
not shown). These results suggest that thrombin stimulates 
the  autophosphorylating activity of pp125 rAK, though we 
cannot absolutely rule out the involvement of another kinase 
which is activated by thrombin. 
The activation of pp125 FAK phosphorylation in vivo and in 
vitro was examined under several additional experimental 
conditions. To determine whether tyrosine phosphorylation 
of pp125 F~ was dependent on fibrinogen binding to GP llb- 
IIIa, platelets were preincubated with a GP IIb-NIa-specific 
rnAb (7E3) that prevents fibrinogen binding to this receptor 
(8). This treatment was used to prevent aggregation as an al- 
ternative for the use of Glanzmann's platelets because the 
Figure 3. Stimulation of pp125 FAK in vitro tyrosine kinase activity. 
(A) Gel-filtered  platelets were stirred in the absence of  agonist (lane 
1), or in the presence of thrombin (THR; 1 U/ml) for 1 min (lane 
2) or 4 min (lanes 3 and 4) and lysed in RIPA  buffer. Lysates were 
incubated with  anti-pp125  FAK mAb  2A7  plus  RAM  (pp125r~K; 
lanes 1-3) or with RAM alone (RAM; lane 4). The immunocom- 
plexes were incubated with [T~2p]ATP for 5 min to allow for in 
vitro phosphorylation. Phosphorylated proteins were separated on 
SDS/Z5%  polyacrylamide gels. (B)  For preferential detection 
of phosphotyrosine-contalning proteins, the gel shown in A was 
treated with 1 M KOH at 56~  for 2 h (9) to preferentially  hydrolyze 
phosphoserine and phosphothreonine. 
availability of these genetically defective platelets is limited. 
A  polyclonal rabbit antiserum to pp125  was employed in 
these immunoprecipitations. Pretreatment with mAb 7E3 in- 
hibited tyrosine phosphorylation of pp125 FAK in thrombin- 
treated platelets (Fig. 4 A) and prevented thrombin-induced 
pp125 F~ phosphorylation in vitro (Fig. 4 B). Pretreatment 
with mAb 6F1, specific for collagen receptor GP Ia-IIa (8) 
did not reduce  the  thrombin-induced phosphorylation of 
pp125 ~AK in vivo (Fig. 4  A,  lane 5) or in vitro (Fig. 4  B, 
lane 5). However, this antibody prevented collagen stimula- 
tion of pp125 FAK phosphorylation in vivo.  There were  no 
detectable differences in the levels of pp125 ag in these im- 
munoprecipitations (as assayed by reprobing with the poly- 
clonai anti-pp125 FAK serum, data not shown). A 62-kD pro- 
tein  was  also  detected  in  the  in  vitro  kinase  assays  of 
anti-pp125 F^K immunoprecipitates from thrombin- and col- 
lagen-treated cells; however, the phosphorylation of  this pro- 
tein did not correlate with pp125 FAK phosphorylation. These 
results indicate the stimulation of the phosphorylation activ- 
ity of pp125  F~ is dependent on fibrinogen-binding to GPab- 
IIIa in both thrombin- and collagen-treated platelets,  and 
demonstrate a correlation between tyrosine phosphorylation 
of pp125 FAK in vivo and activation of the in vitro phosphory- 
lation activity of pp125 rA~. 
To examine whether fibrinogen binding to GP llb-IIla is 
sufficient to stimulate pp125  F~ phosphorylation, or whether 
subsequent platelet aggregation is required for this event, 
platelets were activated by thrombin or ADP and epineph- 
rine in the absence of stirring (Fig. 5). Under these condi- 
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tyrosine kinase activity associated 
with  pp125 FA~  is  dependent  on 
the integrin GP llb-IIIa. Gel-ill- 
tered platelets unstimulated (UN; 
lane 2), or stimulated with throm- 
bin (THR; lanes 1, 3, 4, and 5) or 
collagen (COL; lanes 6, 7, and 8) 
were lysed in RIPA buffer.  Plate- 
lets were preincubated for 20 min 
with mAb 7E3 that interacts with 
GP m)-IIIa (7E3/THR,  lanes 4 
and 8) or with mAb 6F1, which 
interacts  with  GP  Ia-lla  (6F1/ 
COL;  lanes  5  and  7).  Lysates 
were incubated with anti-ppt25  F~ 
polyclonal rabbit serum or nor- 
real rabbit serum (NRS) as indi- 
cated.  The  immunoprecipitates 
were either probed on immuno- 
blots with mAbs specific for phos- 
photyrosine residues (A) or incu- 
bated with  10 #C  ['t32p]ATP  as 
described in Materials and Meth- 
o(ts (B) to allow for in vitro phos- 
phorylation. The gel shown in B 
was treated with alkali (9). 
tions,  GP IIb-IIIa is activated and is capable of binding  to 
fibrinogen (4,  14);  however, no aggregation takes place (as 
previously reported [14] and as monitored in this experiment 
by aggregometry, data not shown).  In platelets treated with 
thrombin,  granule  secretion  takes  place  in  the  absence  of 
stirring  ([14]  and as monitored  in this  experiment by a  lu- 
ciferase  assay of ATP secretion  using  the  lumiaggregome- 
ter). In the absence of stirring, we did not detect any tyrosine 
phosphorylation  of pp125 yAK in  platelets  treated  with  the 
strong  agonist,  thrombin,  or the combination  of relatively 
Figure  5.  Platelet aggregation is 
required  for stimulation of tyro- 
sine phosphorylation of pp125  ~a~. 
Gel-filtered  platelets unstimulated 
(UN; lane 1) or stimulated with 
thrombin (THR; lanes 2,  3,  and 
6) or a combination of ADP, epi- 
nephrine,  and  fibrinogen (ADP/ 
EPI; lanes 4 and 5) were either 
left unstirred  (lanes 2  and 4) or 
stirred (lanes 1, 3, 5, and 6) for 
1 min before lysing in RIPA buffer. 
Platelet aggregation and secretion 
of ATP were monitored by lumi- 
aggregometry. Lysates were incu- 
bated with the  polyelonal rabbit 
anti-pp125 r~K  serum  or  normal 
rabbit serum (NRS).  (A) lmmu- 
noprecipitated proteins were ana- 
lyzed  on  immunoblots  probed 
with mAbs specific for phospho- 
tyrosine  residues.  (B)  The  im- 
mune complexes were incubated 
with  10  /zCi  ['y32P]ATP (as  de- 
scribed in Materials and Methods) 
to  allow  for  in  vitro phosphor- 
ylafion. Phosphorylated proteins 
were separated on an SDS/7.5% 
polyacrylamide gel and the gel was alkali-treated as described in Materials and Methods. The level of ATP secreted from dense granules 
of  unstirred platelets treated with thrombin or collagen was equivalent to that detected in stirred samples, indicating that the level of  thrombin 
activation of platelet secretion was not affected by platelet stirring. 
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4). In addition, there was only a minimal level of pp125 FAK 
phosphorylation in  vitro  in pp125 FAK immunoprecipitates 
extracted from unstirred, agonist-treated platelets (Fig. 5 B). 
These results strongly suggest that fibrinogen binding to GP 
IIb-IIIa is  not sufficient to induce pp125 F^K phosphoryla- 
tion, and that subsequent events that occur during the pro- 
cess of aggregation are necessary to activate tyrosine phos- 
phorylation of pp125 FAK. 
pp125 rA~ is  localized in focal adhesions in CEFs  (28). 
These cellular structures include the integrin receptors and 
associated cytoskeletal proteins, including actin. Since actin 
polymerization is induced after thrombin treatment of plate- 
lets (6, 7, 13, 21), we examined whether the phosphorylation 
of pp125 FAK is  affected by  agents  that  disrupt  the  actin 
cytoskeleton. Platelets were pretreated with  10/zM cyto- 
chalasin D (CD) which blocked agonist-induced actin poly- 
merization in platelets (6,  7,  13,  21),  but did not inhibit 
thrombin- or collagen-induced platelet aggregation (data not 
shown). Pretreatment with CD completely blocked tyrosine 
phosphorylation of pp125 FA~ in thrombin or collagen stimu- 
lated platelets (Fig. 6 A). In addition, CD pretreatment of 
platelets incubated with collagen prevented the stimulation 
of pp125 FAK phosphorylating activity as assayed in these im- 
munocomplex kinase assays (Fig.  6 B).  There was no in- 
crease in tyrosine phosphorylation of pp125 FAK after longer 
periods  of thrombin  treatment  (data  not  shown).  These 
results suggest that cytochalasin D disrupts actin-dependent 
cytoskeletal  interactions  that  are  necessary  for  tyrosine 
phosphorylation  of pp125 FAK and  activation  of  its  phos- 
phorylating activity. 
Discussion 
Previous studies in platelets provided the first evidence that 
integrin-mediated intracellular signaling may involve protein 
tyrosine phosphorylation (11, 14). The phosphorylation of 
several proteins induced by thrombin was inhibited under 
conditions where fibrinogen binding to its integrin receptor, 
GP IIb-IIIa, was blocked (11, 14). These results raised the 
possibility that fibrinogen-dependent engagement of GP fib- 
IIIa, and subsequent platelet aggregation, results in the acti- 
vation of a  protein  tyrosine kinase.  A  candidate kinase, 
pp125 FAt, was originally identified in studies of a phospho- 
tyrosine-containing  protein from normal and Src-transformed 
CEFs (22). The evidence that this protein is localized in focal 
adhesions (28), and that it is phosphorylated on tyrosine af- 
ter cross-linking integrins on human carcinoma ceils (L. J. 
Kornberg and R. L. Juliano, personal communication) or af- 
ter plating NIH-3T3 cells or CEFs on fibronectin matrices 
(J.  L. Guan, I.  Chackalaparampil, and D.  Shalloway, per- 
sonal communication; M. D. Schaller, B. S. Cobb, and J. T. 
Parsons, unpublished results), suggested that engagement of 
integrin molecules could potentially alter the activity of this 
kinase. 
In  this  report  we  demonstrate  that  pp125 FAK is  phos- 
phorylated on tyrosine after thrombin or collagen treatment 
of  platelets  and  that  pp125 ~AK  molecules  isolated  from 
agonist-treated platelets display elevated levels of tyrosine 
phosphorylation in vitro in immune-complex kinase assays. 
These  results  show a  correlation between tyrosine phos- 
phorylation in vivo and the activation of the in vitro phos- 
Figure 6.  Treatment of platelets with cytochalasin D blocks acti- 
vation of the  in  vitro  tyrosine kinase activity associated with 
pp125  FAK. Gel-filtered platelets unstimulated (UN; lane  2),  or 
stimulated with thrombin (TH; lanes 1,  3,  and 4),  or collagen 
(COL; lanes 5 and 6), were lysed with RIPA buffer. Parallel sam- 
ples were pretreated with 10 #M CD for 20 min before stimulation 
with thrombin (CD +  THR; lane 4) or collagen (CD and COL; 
lane 6). Lysates were incubated with anti-pp125  FAK mAb 2A7 and 
RAM (lanes  2-6) or with RAM alone (RAM; lane 1). (A) Immuno- 
precipitated proteins were analyzed on immunoblots probed with 
mAbs specific for phosphotyrosine residues. The 97-K Ig band 
represents a single dimer of the heavy and light immunoglobulin 
chains. (B) The immunocomplexes  were incubated with 10/~Ci 
[.y32p]ATP (as described in Materials and Methods) to allow for in 
vitro phosphorylation. Phosphorylated proteins were separated on 
SDS/7.5% polyacrylamide gels. 
phorylating activity associated with pp125 FAK. In addition, 
we demonstrate that activation of tyrosine phosphorylation 
of pp125 FAK both in vivo and in vitro is dependent on events 
induced by fibrinogen binding to GP IIb-IIIa. pp125 F^K was 
not phosphorylated on tyrosine after thrombin or collagen 
treatment of GP lTo-IIIa-deficient platelets from donors with 
Glanzmann's thrombasthenia, and there was no detectable 
stimulation of pp125FAK-associated phosphorylating activity 
in vitro in platelets pretreated with a mAb to GP IIb-Ula to 
block fibrinogen binding. In addition, tyrosine phosphoryla- 
tion of pp125 FAt in vivo and in vitro required platelet stir- 
ring, suggesting that fibrinogen binding to GP IIb-IIIa alone 
is  not sufficient to  induce pp125 FAt phosphorylation and 
that subsequent integrin-dependent events that accompany 
platelet aggregation are required for pp125 FAK phosphoryla- 
tion. These results strongly support the possibility that tyro- 
sine  phosphorylation of pp125 F~  occurs  downstream  of 
platelet aggregation mediated by fibrinogen binding to GP 
IIb-IIIa, and thus implicate pp125 FAx as a candidate kinase 
that may be responsible for GP IIb-I/Ia-dependent tyrosine 
phosphorylation events. 
These results extend the preliminary studies performed in 
other cell types which showed that engagement and cluster- 
ing  of  integrin-family  fibronectin  receptors  (by  mAb- 
crossing or binding to a fibronectin matrix) causes an induc- 
tion of tyrosine phosphorylation of pp125 F~ (J. L. Guan, I. 
Chackalaparampil, and D. ShaUoway, personal communica- 
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cation; M. D. Schaller, B. S. Cobb, andJ. T. Parsons, unpub- 
lished results). Taken together, all of these results suggest a 
link between integrin receptors, tyrosine phosphorylation of 
cellular proteins and the activation of tyrosine phosphoryla- 
tion of pp125 FA~. 
It is important to establish the mechanisms involved in 
coupling integrin receptors  with protein tyrosine kinases. 
The induction of tyrosine phosphorylation of pp125 rAK by 
collagen in solution was dependent on fibrinogen binding to 
GP IIb-I/Ia,  suggesting that pp125 vAz phosphorylation oc- 
curs "downstream" from platelet aggregation (mediated by 
fibrinogen binding to GP IIb-l/Ia), and that engagement of 
the  collagen  receptor,  GP  Ia-IIa,  is  not  sufficient  for 
pp125 FAK phosphorylation. 
Interactions between integrins  and cytoskeletal protein 
complexes that include actin microfilaments might form the 
framework upon which tyrosine kinases and other signaling 
enzymes associate at the plasma membrane. This possibility 
is consistent with recent evidence indicating that GP IIb-llIa 
as well as several enzymes, including phosphatidylinositol 
Y-kinase, diacylglycerol kinase, and pp60  ~, associate with 
a detergent-insoluble cell fraction following platelet activa- 
tion (15, 35). Furthermore, we have found that the associa- 
tion of pp60  ~  with this fraction is dependent on GP IIb-IIIa 
because this kinase is not found in the Triton-insoluble frac- 
tion of thrombin-treated platelets from GP IIb-IIIa-deficient 
patients  with  Glanzmann's thrombasthenia  (E.  Clark,  L. 
Lipfert, and J.  S. Brugge, unpublished data). 
The results presented in this report show a strong correla- 
tion between tyrosine phosphorylation of pp125 FAK in vivo 
and enhanced phosphorylation of pp125 FAK in immune com- 
plex kinase assays in vitro. In each assay in which duplicate 
immunoprecipitates were assayed for in vivo tyrosine phos- 
phorylation  and  in  vitro  phosphorylation  activity  (Figs. 
4-6),  conditions that prevented  tyrosine phosphorylation 
of pp125 FAz in vivo also inhibited the phosphorylation of 
pp125 FAK in vitro. These results suggest that tyrosine phos- 
phorylation of pp125 FA~ by another kinase or by autophos- 
phorylation might stimulate the phosphorylating activity of 
this kinase. Alternatively, autophosphorylation of pp125 FAK 
in vivo may not affect its catalytic activity, but merely be a 
consequence of its "activated" state. Further studies to deter- 
mine whether pp125 FAz is phosphorylated in vivo by auto- 
phosphorylation, and whether this phosphorylation is neces- 
sary for its in vitro phosphorylating activity are in progress. 
Although we can not rule out the possibility that pp125 F~ 
is phosphorylated in immunocomplexes by an associated 
protein tyrosine kinase, our current data does not strongly 
support this possibility. In anti-pp125 ~AK immunocomplexes 
formed with mAb 2A7, we detected a 56-kD alkali-stable 
phosphorylated protein whose phosphorylation correlated 
with pp125 ~AK phosphorylation (Fig. 3). However,  this pro- 
tein was not detected in any of the in vitro kinase assays using 
the polyclonal rabbit anti-pp125 FAK serum. A 62-kD protein 
was  detected in  the  rabbit  anti-pp125 ~AK immunoprecipi- 
tares; however,  the phosphorylation of this protein did not 
correlate with pp125 FAz phosphorylation in vitro (Figs. 4 
and  5)  and,  whereas  pp125 FAK  phosphorylating  activity 
could be removed by preclearing with anti-pp125 F^z serum, 
this treatment did not diminish the  62-kD  protein phos- 
phorylation (data not shown). The identity of  these coprecip- 
itating proteins and the basis for their precipitation by the an- 
tibodies to pp125 FAK are not known. 
In thrombin-treated platelets, tyrosine phosphorylation of 
several proteins is dependent on aggregation mediated by 
fibrinogen binding to GP Ilb-IIIa (11, 14). Any of these pro- 
teins are candidate targets of pp125 ~  kinase activity. In 
contrast, spreading of NIH-3T3 cells on a fibrinogen matrix 
leads  to  a  much  more  limited tyrosine phosphorylation 
response  (16).  In these  cells,  only a  diffuse band of Mr 
115,000-130,000,  and  a  few minor phosphotyrosine-con- 
taining  proteins  were  detected  in  immunoblots  probed 
with antibodies to phosphotyrosine. Although this diffuse 
Mr  115,000-130,000  immunoreactive band  could contain 
other  phosphotyrosine-containing proteins  in  addition to 
pp125 rAK, these results  suggest that there are only a  few 
candidate  targets  of pp125 Faz  activity  in  these  cells.  In 
platelets, we have found that the protein tyrosine kinases Src, 
Yes,  Fyn,  and  Lyn  redistribute  to  the  triton-insoluble, 
cytoskeleton-rich cell fraction in an aggregation-dependent 
manner (E.  Clark, L. Lipfert, and J. Brugge, unpublished 
observations). These protein tyrosine kinases could also be 
responsible  for the phosphorylation of substrate  proteins 
following aggregation due to their redistribution to this cyto- 
skeletal fraction. The differences in integrin-regulated tyro- 
sine phosphorylation of cellular proteins  in platelets and 
other cell types suggest that there are cell-type or integrin- 
specific targets of adhesion-regulated tyrosine kinases. 
The platelet proteins that are phosphorylated on tyrosine 
in an aggregation-dependent fashion could be responsible for 
the activation of intracellular signaling pathways necessary 
for cellular processes that are dependent on platelet aggrega- 
tion (i.e., activation of the NA§  § pump or calpain activa- 
tion). Further studies are necessary to determine whether 
there is a cause-effect relationship between these events and 
to determine the function of  proteins that are phosphorylated 
on  tyrosine  following  platelet  aggregation  mediated  by 
fibrinogen binding to GP IIb-IIIa. 
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